{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:50:58Z","timestamp":1791129058073,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL39006"],"award-info":[{"award-number":["HL39006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL77398"],"award-info":[{"award-number":["HL77398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL73753"],"award-info":[{"award-number":["HL73753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association Established Investigator"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emory University School of Medicine Medical Student Summer Research Program"},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Atlanta Veterans Affairs Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Atrial fibrillation (AF) has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared serum markers of oxidation and associated inflammation in individuals with or without AF.<\/jats:p>\n                  <jats:p>Methods: Serum markers of oxidative stress and inflammation were compared in a cross-sectional, case-control design study of 40 male individuals, with or without persistent or permanent AF, who were matched for age, sex, diabetes, and smoking status, known confounding variables for the measurement of oxidative stress. We used derivatives of reactive oxidative metabolites (DROMs) and ratios of oxidized to reduced glutathione (Eh GSH) and cysteine (Eh CySH) to quantify oxidative stress. We also measured inflammatory markers, including high-sensitivity C-reactive protein, interleukins 1\u03b2 and 6, and tumor necrosis factor \u03b1.<\/jats:p>\n                  <jats:p>Results: Univariate, conditional logistical regression analysis showed that oxidative stress but not inflammatory markers were statistically associated with AF (P &amp;lt;0.05). The increase in the odds ratios for AF for Eh GSH, Eh CySH, and DROMs were 6.1 (95% CI, 1.3\u201328.3; P = 0.02), 13.6 (95% CI, 2.5\u201374.1; P = 0.01), and 15.9 (95% CI, 1.7\u2013153.9; P = 0.02), respectively. There was a stronger correlation between Eh GSH and Eh CySH (r = 0.66) than between Eh GSH and DROMs (r = 0.41). In multivariate analysis corrected for statins and other AF risk factors differing between the groups, the association of AF and oxidative stress remained significant.<\/jats:p>\n                  <jats:p>Conclusions: These data suggest that oxidative stress markers may have predictive value in AF management.<\/jats:p>","DOI":"10.1373\/clinchem.2006.083923","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T20:40:07Z","timestamp":1183063207000},"page":"1652-1657","source":"Crossref","is-referenced-by-count":184,"title":["Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation"],"prefix":"10.1093","volume":"53","author":[{"given":"Robert B","family":"Neuman","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L","family":"Bloom","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA"},{"name":"Division of Cardiology, Atlanta Veterans Affairs Medical Center, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Shukrullah","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA"},{"name":"Division of Cardiology, Atlanta Veterans Affairs Medical Center, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey A","family":"Darrow","sequence":"first","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kleinbaum","sequence":"first","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean P","family":"Jones","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Samuel C","family":"Dudley","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA"},{"name":"Division of Cardiology, Atlanta Veterans Affairs Medical Center, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"2020030521291253300_R1","doi-asserted-by":"crossref","unstructured":"Dudley SC, Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulus L, Fukai T, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation2005;112:1266-1273.","DOI":"10.1161\/CIRCULATIONAHA.105.538108"},{"key":"2020030521291253300_R2","doi-asserted-by":"crossref","unstructured":"Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res2005;97:629-636.","DOI":"10.1161\/01.RES.0000183735.09871.61"},{"key":"2020030521291253300_R3","doi-asserted-by":"crossref","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation2003;108:3006-3010.","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"2020030521291253300_R4","doi-asserted-by":"crossref","unstructured":"Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol2006;108:346-353.","DOI":"10.1016\/j.ijcard.2005.05.021"},{"key":"2020030521291253300_R5","doi-asserted-by":"crossref","unstructured":"Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg2005;79:1530-1535.","DOI":"10.1016\/j.athoracsur.2004.10.004"},{"key":"2020030521291253300_R6","doi-asserted-by":"crossref","unstructured":"Jones DP, Mody VC, Jr, Carlson JL, Lynn MJ, Sternberg P, Jr. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med2002;33:1290-1300.","DOI":"10.1016\/S0891-5849(02)01040-7"},{"key":"2020030521291253300_R7","doi-asserted-by":"crossref","unstructured":"Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP, et al. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med2003;35:1582-1588.","DOI":"10.1016\/j.freeradbiomed.2003.09.006"},{"key":"2020030521291253300_R8","doi-asserted-by":"crossref","unstructured":"Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P, Jr, Reed RL, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med1998;24:699-704.","DOI":"10.1016\/S0891-5849(97)00286-4"},{"key":"2020030521291253300_R9","doi-asserted-by":"crossref","unstructured":"Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis2005;178:115-121.","DOI":"10.1016\/j.atherosclerosis.2004.08.007"},{"key":"2020030521291253300_R10","doi-asserted-by":"crossref","unstructured":"Jones DP, Carlson JL, Samiec PS, Sternberg P, Jr, Mody VC, Jr, Reed RL, et al. Glutathione measurement in human plasma: evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta1998;275:175-184.","DOI":"10.1016\/S0009-8981(98)00089-8"},{"key":"2020030521291253300_R11","doi-asserted-by":"crossref","unstructured":"Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol1998;82:2N-9N.","DOI":"10.1016\/S0002-9149(98)00583-9"},{"key":"2020030521291253300_R12","doi-asserted-by":"crossref","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA1994;271:840-844.","DOI":"10.1001\/jama.271.11.840"},{"key":"2020030521291253300_R13","doi-asserted-by":"crossref","unstructured":"Marin F, Pascual DA, Roldan V, Arribas JM, Ahumada M, Tornel PL, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol2006;97:55-60.","DOI":"10.1016\/j.amjcard.2005.07.124"},{"key":"2020030521291253300_R14","doi-asserted-by":"crossref","unstructured":"Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol2006;97:1490-1493.","DOI":"10.1016\/j.amjcard.2005.11.082"},{"key":"2020030521291253300_R15","doi-asserted-by":"crossref","unstructured":"Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, et al. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res2005;97:1262-1269.","DOI":"10.1161\/01.RES.0000195844.31466.e9"},{"key":"2020030521291253300_R16","doi-asserted-by":"crossref","unstructured":"Shang LL, Dudley SC, Jr. Tandem promoters and developmentally regulated 5\u2032 and 3\u2032 mRNA untranslated regions of the mouse scn5a cardiac sodium channel. J Biol Chem2005;280:933-940.","DOI":"10.1074\/jbc.M409977200"},{"key":"2020030521291253300_R17","doi-asserted-by":"crossref","unstructured":"Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol2002;22:300-305.","DOI":"10.1161\/hq0202.104081"},{"key":"2020030521291253300_R18","doi-asserted-by":"crossref","unstructured":"Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation2004;110:2313-2319.","DOI":"10.1161\/01.CIR.0000145163.56529.D1"},{"key":"2020030521291253300_R19","doi-asserted-by":"crossref","unstructured":"Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res2004;62:105-111.","DOI":"10.1016\/j.cardiores.2004.01.018"},{"key":"2020030521291253300_R20","doi-asserted-by":"crossref","unstructured":"Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest2005;128:3421-3427.","DOI":"10.1378\/chest.128.5.3421"},{"key":"2020030521291253300_R21","doi-asserted-by":"crossref","unstructured":"Zarauza J, Rodriguez Lera MJ, Farinas Alvarez C, Hernando JP, Ceballos B, Gutierrez B, et al. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion.]. Rev Esp Cardiol2006;59:125-129.","DOI":"10.1016\/S1885-5857(06)60120-5"},{"key":"2020030521291253300_R22","doi-asserted-by":"crossref","unstructured":"Conway DS, Buggins P, Hughes E, Lip GY. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol2004;43:2075-2082.","DOI":"10.1016\/j.jacc.2003.11.062"},{"key":"2020030521291253300_R23","doi-asserted-by":"crossref","unstructured":"Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation1997;96:3542-3548.","DOI":"10.1161\/01.CIR.96.10.3542"},{"key":"2020030521291253300_R24","doi-asserted-by":"crossref","unstructured":"Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder?. Eur Heart J2006;27:136-149.","DOI":"10.1093\/eurheartj\/ehi645"},{"key":"2020030521291253300_R25","doi-asserted-by":"crossref","unstructured":"Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohno H, et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothoracic Surg2006;29:501-505.","DOI":"10.1016\/j.ejcts.2005.12.028"},{"key":"2020030521291253300_R26","doi-asserted-by":"crossref","unstructured":"Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J1989;8:3773-3779.","DOI":"10.1002\/j.1460-2075.1989.tb08554.x"},{"key":"2020030521291253300_R27","doi-asserted-by":"crossref","unstructured":"De Vecchi E, Pala MG, Di Credico G, Agape V, Paolini G, Bonini PA, et al. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart1998;79:242-247.","DOI":"10.1136\/hrt.79.3.242"},{"key":"2020030521291253300_R28","doi-asserted-by":"crossref","unstructured":"Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res2001;89:E32-E38.","DOI":"10.1161\/hh1801.097644"},{"key":"2020030521291253300_R29","doi-asserted-by":"crossref","unstructured":"Guazzi M, Belletti S, Bianco E, Lenatti L, Maurizio GD. Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes. Different results with cardioversion. Am J Physiol2006;291:H921-H928.","DOI":"10.1152\/ajpheart.00986.2005"},{"key":"2020030521291253300_R30","doi-asserted-by":"crossref","unstructured":"Choudhary G, Dudley SC, Jr. Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail2002;8:148-155.","DOI":"10.1111\/j.1527-5299.2002.00716.x"},{"key":"2020030521291253300_R31","doi-asserted-by":"crossref","unstructured":"Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol2004;122:339-352.","DOI":"10.1007\/s00418-004-0696-7"},{"key":"2020030521291253300_R32","unstructured":"Adams JD, Jr, Lauterburg BH, Mitchell JR. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther1983;227:749-754."}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/53\/9\/1652\/32687896\/clinchem1652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/53\/9\/1652\/32687896\/clinchem1652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T21:40:21Z","timestamp":1583444421000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/53\/9\/1652\/5627596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2007,9,1]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2006.083923","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,9,1]]},"published":{"date-parts":[[2007,9,1]]}}}